Susan R. Atlas

Affiliations: 
Biomedical Sciences University of New Mexico, Albuquerque, NM, United States 
Area:
Genetics, Computer Science, Biostatistics Biology, Bioinformatics Biology
Google:
"Susan Atlas"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Edwards JS, Atlas SR, Wilson SM, et al. (2014) Integrated statistical and pathway approach to next-generation sequencing analysis: a family-based study of hypertension. Bmc Proceedings. 8: S104
Urtishak KA, Edwards AY, Wang LS, et al. (2013) Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia. Blood. 121: 2689-703
Harvey RC, Kang H, Roberts KG, et al. (2013) Development and Validation Of a Highly Sensitive and Specific Gene Expression Classifier To Prospectively Screen and Identify B-Precursor Acute Lymphoblastic Leukemia (ALL) Patients With a Philadelphia Chromosome-Like (“Ph-like” or “BCR-ABL1-Like”) Signature For Therapeutic Targeting and Clinical Intervention Blood. 122: 826-826
Li-San W, Teachey DT, Sarah TK, et al. (2013) PI3K/AKT/mTOR Signaling Is a Significant Druggable Pathway In Infant Acute Lymphoblastic Leukemia (ALL) Blood. 122: 1669-1669
Kang H, Wilson CS, Harvey RC, et al. (2012) Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study. Blood. 119: 1872-81
Ho A, Murphy M, Wilson S, et al. (2011) Sequencing by ligation variation with endonuclease V digestion and deoxyinosine-containing query oligonucleotides. Bmc Genomics. 12: 598
Harvey RC, Mullighan CG, Wang X, et al. (2010) Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood. 116: 4874-84
Kang H, Chen IM, Wilson CS, et al. (2010) Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. Blood. 115: 1394-405
Kang H, Wilson CS, Harvey RC, et al. (2010) Gene Expression Profiling Reveals Genes Predictive of Outcome In Infant Acute Lymphoblastic Leukemia (ALL) and Distinctive Age-Related Gene Expression Profiles (< 90 Days vs. > 90 Days): A Children's Oncology Group Study Blood. 116: 412-412
Urtishak KA, Wang L, Harvey R, et al. (2010) Infant Acute Lymphoblastic Leukemias Are Pan-Sensitive to Obatoclax Across molecular/Cytogenetic Subtypes, Especially MLL-ENL, and gene Expression Profiles Determine Obatoclax IC50: A Report on the Children's Oncology Group (COG) P9407 Trial Blood. 116: 2757-2757
See more...